LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool
Individuals with a suspected diagnosis of leukodystrophy may be eligible to participate in a research study investigating the efficacy of whole genome sequencing as a first-line diagnostic tool.